Aqr Capital Management LLC Corcept Therapeutics Inc Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 315,955 shares of CORT stock, worth $21.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
315,955
Previous 239,055 32.17%
Holding current value
$21.5 Million
Previous $7.77 Million 88.2%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$29.51 - $46.26 $2.27 Million - $3.56 Million
76,900 Added 32.17%
315,955 $14.6 Million
Q2 2024

Aug 14, 2024
SELL
$22.21 - $34.48 $429,830 - $667,291
-19,353 Reduced 7.49%
239,055 $7.77 Million
Q1 2024

May 15, 2024
BUY
$21.1 - $27.46 $3.52 Million - $4.59 Million
166,975 Added 182.62%
258,408 $6.51 Million
Q4 2023

Feb 14, 2024
BUY
$24.82 - $32.88 $285,132 - $377,725
11,488 Added 14.37%
91,433 $2.97 Million
Q3 2023

Nov 14, 2023
BUY
$21.97 - $33.8 $9,139 - $14,060
416 Added 0.52%
79,945 $2.18 Million
Q2 2023

Aug 14, 2023
SELL
$21.44 - $25.15 $101,732 - $119,336
-4,745 Reduced 5.63%
79,529 $1.77 Million
Q1 2023

May 15, 2023
BUY
$19.2 - $24.47 $258,950 - $330,026
13,487 Added 19.05%
84,274 $1.83 Million
Q4 2022

Feb 14, 2023
SELL
$19.95 - $29.96 $43,331 - $65,073
-2,172 Reduced 2.98%
70,787 $1.44 Million
Q3 2022

Nov 14, 2022
SELL
$24.7 - $29.12 $449,861 - $530,362
-18,213 Reduced 19.98%
72,959 $1.87 Million
Q2 2022

Aug 15, 2022
BUY
$17.33 - $25.3 $134,966 - $197,036
7,788 Added 9.34%
91,172 $2.17 Million
Q1 2022

May 16, 2022
BUY
$16.53 - $25.21 $136,636 - $208,385
8,266 Added 11.0%
83,384 $1.88 Million
Q4 2021

Feb 14, 2022
SELL
$17.1 - $23.34 $324,985 - $443,576
-19,005 Reduced 20.19%
75,118 $1.49 Million
Q3 2021

Nov 15, 2021
SELL
$19.68 - $22.53 $56,580 - $64,773
-2,875 Reduced 2.96%
94,123 $1.85 Million
Q2 2021

Aug 16, 2021
SELL
$19.97 - $24.43 $122,216 - $149,511
-6,120 Reduced 5.93%
96,998 $2.13 Million
Q1 2021

May 17, 2021
SELL
$23.49 - $30.56 $975,845 - $1.27 Million
-41,543 Reduced 28.72%
103,118 $2.45 Million
Q4 2020

Feb 16, 2021
SELL
$16.78 - $27.3 $2.07 Million - $3.36 Million
-123,166 Reduced 45.99%
144,661 $3.78 Million
Q3 2020

Nov 16, 2020
SELL
$12.46 - $19.98 $653,340 - $1.05 Million
-52,435 Reduced 16.37%
267,827 $4.66 Million
Q2 2020

Aug 17, 2020
BUY
$11.0 - $18.26 $193,908 - $321,887
17,628 Added 5.82%
320,262 $5.39 Million
Q1 2020

May 15, 2020
BUY
$10.11 - $14.04 $1.81 Million - $2.51 Million
178,597 Added 143.99%
302,634 $3.6 Million
Q4 2019

Feb 14, 2020
SELL
$12.06 - $16.96 $936,832 - $1.32 Million
-77,681 Reduced 38.51%
124,037 $1.5 Million
Q3 2019

Nov 14, 2019
BUY
$10.41 - $14.66 $6,828 - $9,616
656 Added 0.33%
201,718 $2.85 Million
Q2 2019

Aug 14, 2019
BUY
$9.78 - $12.76 $458,427 - $598,112
46,874 Added 30.4%
201,062 $2.24 Million
Q1 2019

May 14, 2019
BUY
$10.03 - $15.71 $316,326 - $495,461
31,538 Added 25.71%
154,188 $1.81 Million
Q4 2018

Feb 14, 2019
SELL
$11.29 - $17.19 $1.31 Million - $1.99 Million
-115,960 Reduced 48.6%
122,650 $1.64 Million
Q3 2018

Nov 15, 2018
SELL
$12.27 - $15.65 $1.49 Million - $1.9 Million
-121,115 Reduced 33.67%
238,610 $3.35 Million
Q2 2018

Aug 14, 2018
BUY
$15.3 - $19.69 $183,248 - $235,827
11,977 Added 3.44%
359,725 $5.66 Million
Q1 2018

May 15, 2018
SELL
$14.59 - $25.5 $5.3 Million - $9.26 Million
-363,267 Reduced 51.09%
347,748 $5.72 Million
Q4 2017

Feb 14, 2018
SELL
$15.77 - $20.72 $3.52 Million - $4.63 Million
-223,369 Reduced 23.91%
711,015 $12.8 Million
Q3 2017

Nov 14, 2017
BUY
$12.3 - $19.3 $11.5 Million - $18 Million
934,384
934,384 $18 Million

Others Institutions Holding CORT

# of Institutions
361
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.28B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email